Literature DB >> 8915230

Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders.

A L Hamilton1, K J Killian, E Summers, N L Jones.   

Abstract

The aim of the study was to compare (1) the intensity of leg effort and dyspnea during exercise and (2) subjective limitations to performance in normal subjects, patients receiving medication for cardiac disorders, patients with pulmonary impairment, patients with pulmonary impairment who were also receiving cardiac medications, patients experiencing chest pain during exercise, and patients who had a reduced exercise capacity but did not have pulmonary impairment and were not receiving cardiac medication. Five hundred seventy-eight subjects rated the intensity of leg effort, discomfort with breathing (dyspnea), and chest pain every minute (Borg scale) during an incremental exercise task (100 kpm/min each minute) to maximum work capacity on a cycle ergometer and following exercise indicated their subjective limitation by completing a simple questionnaire. Leg effort and dyspnea increased systematically with power output in a positively accelerating manner in all groups; both symptoms were significantly more intense in the impaired groups compared with the normal group at submaximal power outputs. In all groups, there was a significant relationship between symptom intensity at submaximal power outputs and the maximal power output achieved. Leg discomfort in combination with breathing discomfort was the predominant subjective limitation in all groups; chest pain in combination with leg and breathing discomfort was the major subjective limitation in individuals with angina. Activation of the sensory systems during exercise is accompanied by a perception of discomfort associated with the peripheral exercising muscles and discomfort with breathing; both discomfort associated with the exercising muscles and discomfort associated with breathing contribute to exercise limitation to a large degree in normal subjects and patients with cardiorespiratory diseases.

Entities:  

Mesh:

Year:  1996        PMID: 8915230     DOI: 10.1378/chest.110.5.1255

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

1.  The Effect of a Short Duration, High Intensity Exercise Intervention on Gait Biomechanics in Patients With COPD: Findings From a Pilot Study.

Authors:  Jennifer M Yentes; Daniel Blanke; Stephen I Rennard; Nicholas Stergiou
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

2.  Is there a conflict between minimizing effort and energy expenditure with increasing velocities of muscle contraction in humans?

Authors:  B Chen; N L Jones; K J Killian
Journal:  J Physiol       Date:  1999-08-01       Impact factor: 5.182

3.  Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function.

Authors:  Jonathan Singer; Edward H Yelin; Patricia P Katz; Gabriela Sanchez; Carlos Iribarren; Mark D Eisner; Paul D Blanc
Journal:  J Cardiopulm Rehabil Prev       Date:  2011 Mar-Apr       Impact factor: 2.081

4.  Reference values for assessing the arms: are we seeing a light at the end of the tunnel?

Authors:  Luciana Dias Chiavegato
Journal:  J Bras Pneumol       Date:  2018 May-Jun       Impact factor: 2.624

Review 5.  New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.

Authors:  Martijn A Spruit; Emiel F M Wouters
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

6.  Gait mechanics in patients with chronic obstructive pulmonary disease.

Authors:  Jennifer M Yentes; Kendra K Schmid; Daniel Blanke; Debra J Romberger; Stephen I Rennard; Nicholas Stergiou
Journal:  Respir Res       Date:  2015-02-28

Review 7.  Optoelectronic Plethysmography has Improved our Knowledge of Respiratory Physiology and Pathophysiology.

Authors:  Isabella Romagnoli; Barbara Lanini; Barbara Binazzi; Roberto Bianchi; Claudia Coli; Loredana Stendardi; Francesco Gigliotti; Giorgio Scano
Journal:  Sensors (Basel)       Date:  2008-12-05       Impact factor: 3.576

Review 8.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

9.  Ascorbate attenuates cycling exercise-induced neuromuscular fatigue but fails to improve exertional dyspnea and exercise tolerance in COPD.

Authors:  Thomas J Hureau; Joshua C Weavil; Simranjit K Sidhu; Taylor S Thurston; Van R Reese; Jia Zhao; Ashley D Nelson; Nathaniel M Birgenheier; Russell S Richardson; Markus Amann
Journal:  J Appl Physiol (1985)       Date:  2020-11-05

Review 10.  Exercise dyspnea in patients with COPD.

Authors:  Loredana Stendardi; Barbara Binazzi; Giorgio Scano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.